To determine and compare outcomes with accepted benchmarks in trauma care at 7 academic level I trauma centers in which patients were treated on the basis of a series of standard operating procedures (SOPs). Background: Injury remains the leading cause of death for those younger than 45 years. This study describes the baseline patient characteristics and well-defined outcomes of persons hospitalized in the United States for severe blunt trauma. Methods: We followed 1637 trauma patients from 2003 to 2009 up to 28 hospital days using SOPs developed at the onset of the study. An extensive database on patient and injury characteristics, clinical treatment, and outcomes was created. These data were compared with existing trauma benchmarks. Results: The study patients were critically injured and were in shock. SOP compliance improved 10% to 40% during the study period. Multiple organ failure and mortality rates were 34.8% and 16.7%, respectively. Time to recovery, defined as the time until the patient was free of organ failure for at least 2 consecutive days, was developed as a new outcome measure. There was a reduction in mortality rate in the cohort during the study that cannot be explained by changes in the patient population.
I njuries continue to be the fifth leading cause of death overall and the leading cause of death for persons younger than 45 years of age in the United States. 1 In 2006, injuries accounted for 179,065 deaths 2 and nearly 2 million hospital discharges. 3 The burden of trauma and its costs to society remain staggering.
Profound physiologic derangement is expected after major trauma and hemorrhagic shock. However, the clinical course after initial resuscitation varies considerably and may be affected by the patient's care. Patients may recover quickly, whereas others experience complicated recoveries including organ dysfunction and/or infections. Studies from large medical centers record the incidence of such complications 4, 5 ; however, these data reflect various supportive care protocols, or none at all, despite reports on the benefits of using protocols in the critically ill patients. 6 Except for the Advanced Trauma Life Support course, standard algorithms are rarely used in resuscitation and trauma critical care, unlike in sepsis, cancer, and cardiovascular disease. Furthermore, trauma study patients are not categorized in a uniform manner to capture mechanism or physiology, thus making generalizations difficult.
Our primary goal was to define outcomes in high-risk, severe blunt trauma patients from 7 level I trauma centers that agreed to follow standard operating procedures (SOPs) for patient treatment. [7] [8] [9] [10] [11] [12] [13] [14] [15] We subsequently compared our clinical outcomes with established prediction models, APACHE II and Trauma Score-Injury Severity Score (TRISS), and another large matched database cohort from the National Trauma Data Bank (NTDB). As a secondary goal, we also developed the concept of Multiple Organ Failure (MOF) time to recovery (TTR) as a novel improved metric to describe more completely the progression of the complex physiologic and anatomic derangements experienced by severely injured trauma patients. Contrary to current dogma, our data confirm that morbidity and mortality continue to exist in the severely traumatized patient. Thus, we hypothesized that through the implementation and quarterly auditing of SOPs, we would be able to document an improvement in clinical outcomes over time. In addition, we hypothesized that improvement in compliance with the use of these SOPs would result in an overall survival benefit that would be better than predicted by both APACHE II and TRISS scores, as well as an NTDB matched cohort. Furthermore, we also set out to demonstrate that TTR correlated well with several demographic features and the clinical status of our cohort, and thus may prove to be a useful measure to evaluate the critically ill trauma patients.
METHODS

Study Design
The Inflammation and the Host Response to Injury is a National Institute of General Medical Sciences large-scale collaborative project ("Glue Grant"). In this observational, prospective study conducted from November 2003 to July 2009 at 7 US level I trauma centers, patients were enrolled if they were critically injured by blunt mechanism, were 16 years old or older, had shock due to hemorrhage defined as base deficit 6 meq/L or more or systolic blood pressure (SBP) less than 90 mm Hg within 60 minutes of arrival to the emergency department (ED) and required initiation of blood transfusion within 6 hours of injury (Supplemental Table 1 , available at http://links.lww.com/SLA/A235). Patient treatment SOPs were developed through literature reviews and comprehensive, quarterly face-to-face meetings, in the year before and during the first year of the study. Processes for auditing compliance were developed to include regular compliance data reports and on-site medical record audits.
Definition of Outcomes and Data Collection
Demographic, clinical, physiological, and outcomes data were abstracted through the first 28 days or intensive care unit (ICU) discharge after injury and uploaded to TrialDB. 16 Study investigators prospectively defined and subsequently published the data definitions 17 that relied wherever possible on existing standards. Trained health care data abstractors participated in meetings and conference calls to ensure uniformity of data abstraction among centers. A dedicated team was responsible for data management, curation, and storage. A clinical data manager performed ongoing quality monitoring to ensure completeness and accuracy including queries submitted to the abstractors to eliminate internal inconsistencies, and missing or implausible values. A 5% random sample of records was selected for review during every site visit when the team reviewed the records for study eligibility, cause of death (if applicable), and the presence/absence of infections and other complications. A waiver of informed consent was granted by the institutional review boards as the data was a limited dataset and the SOPs were used for all patients in the center. Organ dysfunction and hospital mortality were analyzed as outcomes measures. Organ dysfunction assessment was performed using 2 widely accepted postinjury multiple organ dysfunction/failure (MOD/MOF) scores, Marshall MOD, 18 and Denver MOF. 19 The first 48 hours after injury was not included in the assessment for organ failure to exclude the impact of the initial insult and resuscitation upon initial organ function. Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) were defined according to the European-American consensus conference. 20 MOF was defined by adapting the Marshall MOD score to exclude the neurological component. MOF was defined as a MOF score greater than 6 using either score. Other noninfectious and infectious complications were assessed using standardized definitions. Specifically, definitions of nosocomial infections 21 and surgical site infections 22 were those used by the Centers for Disease Control with the exception that superficial surgical site infections and all infectious complications required the presence of a positive microbial culture.
SOP Compliance
The primary goal was to determine overall SOP compliance and determine the relation between SOP compliance and mortality. Compliance to the SOP's was determined from the case report forms using simple rules based on physiologic measurements (described at http://www.gluegrant.org/commonlyreferencedpubs.htm). These measures could not capture the full extent of the SOPs, so the compliance estimates are approximate and the actual compliance may be better than the estimates. The change in the compliance measures over time should reflect the true changes in compliance over the study period.
Time to Recovery
A secondary goal was to identify organ recovery and to assess whether TTR was a valid measure of morbidity. Organ recovery is relatively straightforward to identify when a failing organ requires support, but less intuitive for more subtle degrees of organ dysfunction. Making the assumption that subtle degrees of organ dysfunction have little impact on mortality, we chose to consider an organ system to have recovered when the parameters reflecting normalization of function were present for at least 2 consecutive days (Supplemental Table 2 , available at http://links.lww.com/SLA/A241). Patients who died during the 28-day period were assigned a time to recovery of more than 30 days, whereas patients who were still in organ failure on day 28 were assigned a value of 29 days.
Statistical Analyses
Differences in baseline covariates between survivors and nonsurvivors were assessed using a Wilcoxon test, χ 2 test, or Fisher exact test. Association of baseline covariates and MOF TTR was assessed using Spearman correlation. Differences between observed and predicted mortality for both TRISS 23 and APACHE II 24 and between observed and predicted multiple organ failure 25 were assessed using Flora z statistic. 26 Logistic regression was used to correct the time trend in mortality for important baseline covariates.
We compared our mortality to that of a subset of the NTDB patients who, based on the available nonmissing data, met the following criteria: known outcome (dead on hospital arrival excluded); level I or II trauma center; blunt injury mechanism; ED arrival <24 hours of injury; ED disposition to the ICU or operating room; ED SBP less than 90 mm Hg or ED base deficit more than 6 meq/L; maximum head Abbreviated Injury Scale 27 (AIS) Score less than 6; maximum spine AIS Score less than 6; known age; known Injury Severity Score 28 (ISS). This subset together with our study cohort was stratified into age and ISS quintiles (for a total of 25 strata) and log odds of death was evaluated between the study and NTDB patients using stratified logistic regression.
Survival and TTR plots through study day 28 were made using Kaplan-Meier estimates. To examine the relationship between TTR and MOF, we created a plot of the MOF score over time after injury for each of the 1637 massively injured patients. Analysis was performed in SAS Version 9.2 (SAS Institute Inc., Cary, NC) and 2-sided P ≤0.05 were considered evidence of statistical significance. Table 1 shows patient characteristics upon ED presentation. The data confirmed critical injuries with a mean ISS of 32.1 ± 13.4 and more than half of the injuries due to motor vehicle crashes (MVC). Patients were predominantly male (66.3%), Caucasian (89.1%), and middle-aged with a mean (±SD) age of 42 (± 18) years. Approximately two thirds of the patients presented with ED hypotension, and the degree of soft tissue injury and blood loss were indicative of significant metabolic dysfunction, as measured by mean base deficit of −10.4 ± 5.1 meq/L and lactate of 5.4 ± 3.2 mmol/L. On average, these patients were given 3 times their blood volume in a combination of crystalloid (11 liters) and packed red blood cells (8 units) . These patients were also found to have severe underlying coagulopathy requiring additional blood products.
RESULTS
Study Population
The study population experienced significant complications including ARDS (24.9%), ventilator-associated pneumonia (VAP) (26.5%), and MOF (34.8%) ( Table 2) . Outcomes for patients who died reflect most deaths occurring within the first 7 study days. Overall mortality was 16.7% with only 29.2% of the patients discharged home without assistance; the majority of the surviving patients were transferred to rehabilitation or skilled nursing facilities.
SOP Compliance
A primary study goal was to implement resuscitation and clinical management SOPs to standardize patient care across the trauma centers, and subsequently to examine the impact of these SOPs on clinical outcomes. Initially, protocol compliance within each institution varied (Table 3) ; however, mean compliance improved over time. Significant improvements in compliance included a decrease in tidal volumes in patients with ALI/ARDS (7.5-6.8 mL/kg), a decrease in inappropriate vascular thromboembolic (VTE) prophylaxis (34%-8%), and use of bronchoalveolar lavage for the diagnosis of VAP (72%-100%) (all P < 0.05). Compliance with certain protocols showed little significant improvement despite regular reviews and . Importantly, our overall mortality decreased over the study from 22% in the first 2 years to 11% in the last 2 years (P < 0.01), as demonstrated in Figure 1A . This decrease was significant even if we corrected for baseline age, APACHE II, AIS, New Injury Severity Score (NISS), SBP, and base deficit.
Outcomes Compared to Standardized Benchmarks
To further assess the mortality rates in the context of injury severity, survival was evaluated using several published measures of mortality propensity including TRISS (Fig. 1B) and APACHE II (Fig. 1C ), as well as the observed mortality within a matched cohort from the NTDB during the same period of time ( Fig. 1D ). Of the 2,433,507 NTDB patients, 410,419 with known outcome after blunt trauma arrived at level I or II trauma centers within 24 hours of injury and were sent to the intensive care unit or operating room. Of these, 21,447 had SBP less than 90 or base deficit more than 6 whereas 345,755 were excluded with SBP 90 or more and unknown base deficit. Of these, 2466 had head AIS codes of 1 to 5, but 18,969 were excluded with missing head AIS code. The remaining 2408 NTDB patients with known age and ISS were compared to our study cohort.
On the basis of TRISS, our outcomes were markedly improved in those patients from the most critically ill quintile. In addition, the observed mortality in our cohort was dramatically better than predicted by APACHE II across all quintiles. Our cohort mortality matched to NTDB patients demonstrated a significant improvement in ISS-related mortality, odds ratio of 0.370 (95% CI: 0.314-0.437). In addition, the matched cohort in NTDB, unlike our study population, was found to have a minimal nonsignificant improvement in survival.
Organ Dysfunction and TTR
Although multiple established measures of clinical outcome in critically ill patients exist, they often lack granularity, are narrow in focus, and ineffectively capture multiple physiologic features in complex disorders such as traumatic injury. The concept of TTR from organ dysfunction was examined to develop a more comprehensive parameter. TTR is associated with demographic characteristics including sex and advanced age ( Table 4 ) demonstrated in studies to have poorer outcomes. 29, 30 TTR varied directly with increasing severity of anatomic injury, whether assessed by ISS or overall maximum AIS score. In addition, prolonged TTR was associated with the presence of shock based on initial base deficit or lactate, increasing transfusion requirements, and elevated day 1 glucose levels. We concluded that MOF TTR correlated well with a wide range of features easily ascribed to severely injured, critically ill patients.
As demonstrated, TTR reflects recovery of organ dysfunction independent of the first 7-day mortality. In Figure 2A from top to bottom, the patients are ordered by their TTR. The patients who never had organ dysfunction or recovered rapidly are nearest the top whereas patients with prolonged TTR are toward the bottom. Shades of red represent degree of MOF, blue represents the absence of MOF, and black represents death. Figure 2B is a graphical representation of the same data. Here, we show the proportion of patients who either died, recovered, or remained with organ failure on any given day. As shown, most deaths occur within the first 7 days after injury, whereas the proportion of patients who recovered from MOF continued to increase over time without evidence of recurrent episodes of organ dysfunction during the entire 28 days postinjury with only a small number of patients not recovered by 28 days.
DISCUSSION
This study represents one of the first comprehensive, multiinstitutional assessments of patient and injury characteristics, anatomic and physiological derangement, and outcomes from severe blunt trauma to date using evidence-based patient treatment protocols. Through development of detailed methodologies for study inclusion, data collection, and clinical care, we were able to amass a well-characterized set of 1637 severely injured patients. In addition, our data set is Web-accessible to any investigator at www.gluegrant. org/ and should serve as a rich and novel data resource in critically injured patients.
The common belief has become that morbidity and mortality continue to exist in the severely traumatized patient. Although it is true that the majority of blunt injury patients leave the hospital after an uneventful course, this study describes a cohort that was critically injured, as measured by ISS, and in shock as measured by SBP, base deficit, and lactate levels. By virtue of our inclusion criteria, this cohort represents those individuals at the highest risk for complications and death. These patients exhibited significant mortality and MOF with 39.7% of the patients either dying or having a TTR of more than 14 days. If we are to achieve further advances to reduce morbidity and mortality, then attention must be paid to those most severely injured with shock. Interestingly in Figure 2 , patients who developed MOF did so rapidly without apparent recovery followed by worsening, subsequent organ dysfunction as classically ascribed to the "two-hit hypothesis" of MOF.
A strength of the study is that clinical SOPs were developed, implemented, and audited in areas where data might suggest that practice variations could influence patient outcomes, for example, infections and mortality. In recognition that SOPs have not been widely published or routinely practiced in major US trauma centers, the Journal of Trauma Injury, Infection and Critical Care published these as a series, and they have been adopted for utilization in large federally funded clinical trials. [7] [8] [9] [10] [11] [12] [13] [14] [15] SOP implementation was incremental with increasing compliance for most; only a few protocols persisted without improvement (Table 3 ). Although full compliance was not achievable, 30% to 50% improvements were shown. Moreover, although improvement in protocol compliance is considered essential for outcome improvement, minor absolute changes in compliance have been shown to have a significant clinical benefit, as previously demonstrated for other clinical disorders, such as sepsis. [31] [32] [33] For example in our ARDS SOP, although the observed compliance with ventilator volume protocols increased from only 36% to 46% of patients (Table 3) , actual average tidal volumes decreased in a more clinically relevant manner (7.5-6.8 mL/kg). Of interest, adherence to the SOPs improved with time most likely as a result of compliance report reviews at our quarterly face-to-face investigators' meetings, the site visit audit program, and dashboard compliance monitoring on our Web site. Compliance measures cannot be associated with outcome on an individual patient basis because the most severe patients are most likely to be out of compliance, and, in fact, overruling the SOP, is allowed in extreme situations. Therefore, an ecologic analysis based on group data is the only analysis possible. It cannot substitute for a clinical trial comparing SOP's versus no SOP's, but because the SOP's are evidence-based, such a trial might be unethical. Although mortality improvement may indicate a Hawthorne effect, as demonstrated in Figure 1A , the duration of the impact over 5 years with continued improvement after 5 years strongly suggests a direct effect of the SOPs, along with continued implementation and compliance. Thus, this is one of the first studies in severely injured patients demonstrating improved mortality with implementation of a "trauma bundle." 34 We studied critically ill patients at high risk for complications and death. Despite their massive injuries, patient mortality was only 16.7% compared to a 10% mortality rate reported from the only other prospective outcomes study in trauma, and one that did not require massive injuries, transfusions, or a base deficit for inclusion. 30 In that study, the adjusted mortality to patients who presented with shock, as defined as a SBP less than 90 mm Hg, or significant injury, defined as AIS more than 3, ranged between 8.4% and 29.4%. However, unlike our study, the occurrence of complications, such as MOF, was not evaluated. Thus, our study provides not only a better benchmark for mortality but also for the independent development and recovery of MOF in these patients.
Comparing our mortality or organ failure rates with APACHE II and TRISS predicted rates or with NTDB patients was difficult. One issue was that in the NTDB, there was very little physiological data demonstrating shock or its sequelae (base deficit and lactate level). In fact, base deficit, which is an NTDB data element, was recorded in only a very small proportion (∼4%) of the nearly 1 million patients for the years 2002 to 2007. Although ISS is known to be a strong predictor of mortality when viewed over the entire dynamic range of ISS, it was interesting to note that when limiting comparisons to those with high injury scores, physiological parameters become critically important discriminators. At high ISS values, the presence of shock upon hospital presentation had a profound impact upon outcome. Although physiological parameters and the degree of initial shock have not been included in traditional benchmarks, on the basis of our observations, they should be. This influence of physiology has not been appreciated in previous studies and we believe physiological parameters greatly empower the predictive nature of these models or datasets at high ISS values, rather than merely relying on the severity of injury. In fact, this may be partly the reason for the differences in expected versus observed mortality within NTDB and our current cohort.
This ongoing challenge of inadequate benchmarks for these complex processes is one of the reasons why we have introduced the concept of TTR as a novel outcome benchmark. There are at least 2 potential advantages of TTR: (1) it is more meaningful clinically at the bedside, and (2) in our view, it is easier to recognize multisystem organ recovery signs than arbitrary grades of organ dysfunction. In our study, TTR showed strong correlations with parameters that can comprehensively and accurately describe critically ill patients with severe blunt trauma. A third potential advantage is increased power to detect treatment effects in randomized trials. TTR is similar to ventilator-free days for acute pulmonary dysfunction in that it combines information on both mortality and speed of recovery in survivors. Ventilator-free days has been shown to be a more powerful outcome measure than mortality alone. 35 TTR appears to be a more comprehensive and appropriate monitor for the complexity of the disease response.
Mortality and multiorgan failure remain problematic in patients with severe traumatic injury. This study underscores the importance of 2 critical facets for improving patient care: (1) the implementation of standardized protocols based on best available evidence to enhance clinical practice and (2) use of relevant endpoints for patient outcomes that are not simply defined as lived or died, but integrate complications and organ failure. The morbidity and mortality rates in this study represent improvements over established benchmarks and, thus, should set a high standard for the care of these challenging patients. In addition, by making our unique dataset publicly available, we hope to enable other clinicians to investigate their own hypothesis and/or questions to continue to improve current practice for critically injured patients.
